Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 7653469)

1.

Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis.

Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW.

Am J Epidemiol. 1995 Sep 15;142(6):608-11.

PMID:
7653469
2.

Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case-control study.

Churilla TM, Lesko SL, Brereton HD, Klem M, Donnelly PE, Peters CA.

BMJ Open. 2011 Dec 19;1(2):e000397. doi: 10.1136/bmjopen-2011-000397. Print 2011.

3.

Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.

Agborsangaya CB, Surcel HM, Toriola AT, Pukkala E, Parkkila S, Tuohimaa P, Lukanova A, Lehtinen M.

Eur J Cancer. 2010 Feb;46(3):467-70. doi: 10.1016/j.ejca.2009.11.019.

PMID:
20022237
4.

Dietary vitamin D intake and cancers of the colon and rectum: a case-control study in Italy.

Lipworth L, Bender TJ, Rossi M, Bosetti C, Negri E, Talamini R, Giacosa A, Franceschi S, McLaughlin JK, La Vecchia C.

Nutr Cancer. 2009;61(1):70-5. doi: 10.1080/01635580802348633.

PMID:
19116876
5.

Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies.

Huncharek M, Muscat J, Kupelnick B.

Nutr Cancer. 2009;61(1):47-69. doi: 10.1080/01635580802395733.

PMID:
19116875
6.

Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.

Abbas S, Chang-Claude J, Linseisen J.

Int J Cancer. 2009 Jan 1;124(1):250-5. doi: 10.1002/ijc.23904.

PMID:
18839430
7.

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.

Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W.

Arch Intern Med. 2008 Jun 23;168(12):1340-9. doi: 10.1001/archinte.168.12.1340.

PMID:
18574092
8.

The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1339-43. doi: 10.1158/1055-9965.EPI-08-0162.

9.

Donation frequency, iron loss, and risk of cancer among blood donors.

Edgren G, Reilly M, Hjalgrim H, Tran TN, Rostgaard K, Adami J, Titlestad K, Shanwell A, Melbye M, Nyrén O.

J Natl Cancer Inst. 2008 Apr 16;100(8):572-9. doi: 10.1093/jnci/djn084. Epub 2008 Apr 8.

10.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

11.

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Carcinogenesis. 2008 Jan;29(1):93-9. Epub 2007 Oct 31.

12.

A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.

Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL.

J Natl Cancer Inst. 2007 Jul 18;99(14):1120-9. Epub 2007 Jul 10.

13.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.

Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):783-8.

14.

C-reactive protein concentrations and subsequent ovarian cancer risk.

McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Pollak M, Tao Y, Helzlsouer KJ.

Obstet Gynecol. 2007 Apr;109(4):933-41.

PMID:
17400857
15.

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.

Tuohimaa P, Tenkanen L, Syvälä H, Lumme S, Hakulinen T, Dillner J, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302-7.

16.

Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis.

Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M, Holick MF.

Am J Prev Med. 2007 Mar;32(3):210-6.

PMID:
17296473
17.

Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?

Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J.

Lung Cancer. 2007 Mar;55(3):263-70. Epub 2007 Jan 17.

PMID:
17207891
18.

A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.

Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2006 Oct 15;66(20):10213-9.

19.

Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan).

Lin Y, Kikuchi S, Tamakoshi A, Obata Y, Yagyu K, Inaba Y, Kurosawa M, Kawamura T, Motohashi Y, Ishibashi T; JACC Study Group.

Cancer Causes Control. 2006 Oct;17(8):1077-82.

PMID:
16933058
20.

Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.

Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L.

Clin Endocrinol (Oxf). 2005 Nov;63(5):506-13.

PMID:
16268801
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk